Esta pesquisa tem por objetivo descrever os efeitos das doenças crônicas nãos transmissíveis sobre a função cardiopulmonar de pacientes participantes de um programa de reabilitação cardiopulmonar pós COVID-19. Trata-se de um estudo documental a partir de dados do Centro de Reabilitação Cardiopulmonar do município de Criciúma do período entre novembro de 2020 a janeiro de 2022. Foram conduzidas análises para avaliar a influência das DCNT, como DM, HAS e obesidade, no desempenho cardiopulmonar e de força dos pacientes antes e após a participação no programa de reabilitação. Dentre os pacientes atendidos, a maioria era do sexo feminino (61,3%), a média de idade foi de 54,35 (±12.39) anos. Um total de 41,4% dos participantes tinham HAS e 36,52% eram diagnosticados com DM. Além disso, 26,40% dos pacientes aparentavam obesidade e 82,7% eram sedentários. Apesar de haver uma melhora em todas as variáveis analisadas após a reabilitação, a DM, a hipertensão e a obesidade foram associadas ao pior desempenho cardiopulmonar no início e no fim do estudo. Por fim, os resultados desta pesquisa destacam a complexidade de saúde dos pacientes com doenças crônicas não transmissíveis e reforçam a necessidade de um cuidado multiprofissional e integral aos pacientes pós covid-19.
CARFÌ, A.; BERNABEI, R.; LANDI, F. Persistent symptoms in patients after acute COVID-19. JAMA, v. 324, n. 6, p. 603–605, 9 jul. 2020.
CHEN, R. et al. Influence of blood pressure control and application of renin‐angiotensin‐aldosterone system inhibitors on the outcomes in COVID‐19 patients with hypertension. The Journal of Clinical Hypertension, v. 22, n. 11, p. 1974–1983, 2 out. 2020.
COOPER, B. G. et al. The Global Lung Function Initiative (GLI) Network: bringing the world’s respiratory reference values together. Breathe, v. 13, n. 3, p. e56–e64, set. 2017.
CURCI, C. et al. Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol. European Journal of Physical and Rehabilitation Medicine, v. 56, n. 5, nov. 2020.
DUNCAN, B. B. et al. Doenças crônicas não transmissíveis no Brasil: prioridade para enfrentamento e investigação. Revista de Saúde Pública, v. 46, n. suppl 1, p. 126–134, dez. 2012.
EJAZ, H. et al. COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health, v. 13, n. 12, ago. 2020.
FAYSSOIL, A. et al. Cardiopulmonary Pathophysiological Aspects in the Context of COVID-19 and Obesity. SN Comprehensive Clinical Medicine, v. 3, n. 9, p. 1848–1857, 14 jun. 2021.
FERRETTI, A. et al. Expiratory Flow Limitation and Orthopnea in Massively Obese Subjects. Chest, v. 119, n. 5, p. 1401–1408, maio 2001.
FRANZMANN, K. L. Manejo das condições pós covid por profissionais da saúde:uma revisão integrativa. Monografia—Curso de Enfermagem da Universidade Federal da Fronteira Sul: [s.n.].
GARG, P. et al. The “post‐COVID” syndrome: How deep is the damage?. Journal of Medical Virology, v. 93, n. 2, p. 673–674, 29 set. 2020.
HERMANN, M. et al. Feasibility and Efficacy of Cardiopulmonary Rehabilitation After COVID-19. American Journal of Physical Medicine & Rehabilitation, v. 99, n. 10, p. 865–869, 24 jul. 2020.
HUANG, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, v. 397, n. 10270, p. 220–232, 8 jan. 2021.
KELLY, T. M. et al. Maximum Respiratory Pressures in Morbidly Obese Subjects. Respiration, v. 54, n. 2, p. 73–77, 1988.
KRIEGER, N. Theories for social epidemiology in the 21st century: an ecosocial perspective. International Journal of Epidemiology, v. 30, n. 4, p. 668–677, ago. 2001.
LASZLO, G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax, v. 61, n. 9, p. 744–746, 1 set. 2006.
LAZARUS, R.; SPARROW, D.; WEISS, S. T. Effects of Obesity and Fat Distribution on Ventilatory Function. Chest, v. 111, n. 4, p. 891–898, abr. 1997.
LI, X. et al. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis, v. 10, n. 2, p. 102–108, 5 mar. 2020.
MAHAMAT-SALEH, Y. et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open, v. 11, n. 10, p. e052777, out. 2021.
MOHAMADIAN, M. et al. COVID‐19: Virology, biology and novel laboratory diagnosis. The Journal of Gene Medicine, v. 23, n. 2, 1 fev. 2021.
MOUFFAK, S. et al. Recent advances in management of COVID-19: A review. Biomedicine & Pharmacotherapy, v. 143, p. 112107, nov. 2021.
NÄGELE, M. P. et al. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis, v. 314, p. 58–62, dez. 2020.
ROSA, G. J. DA; SCHIVINSKI, C. I. S. Assessment of respiratory muscle strength in children according to the classification of body mass index. Revista Paulista de Pediatria, v. 32, n. 2, p. 250–255, jun. 2014.
SHEEHY, L. M. Considerations for Postacute Rehabilitation for Survivors of COVID-19. JMIR Public Health and Surveillance, v. 6, n. 2, p. e19462, 8 maio 2020.
TOZATO, C. et al. Reabilitação cardiopulmonar em pacientes pós- COVID-19: série de casos. Rev Bras Ter Intensiva, v. 33, n. 1, p. 167–171, 2021.
YUGAR-TOLEDO, J. C. et al. Disfunção Endotelial e Hipertensão Arterial. Rev. bras. hipertens, p. 84–92, 2015.
ZHANG, J. et al. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis. Epidemiology and Infection, v. 148, 2020.
The Brazilian Journal of Social Technologies is a Qualis B1 publication, according to the Qualis Periódicos CAPES 2017-2020 classification.
The Brazilian Journal of Social Technologies aims to disseminate scientific knowledge through a biannual publication, which is characterized by multithematic and interdisciplinary content aimed, preferably, at the dissemination of work developed by the country's Professional Master's Degrees, in the form of products or processes that can be characterized as Social Technologies. Currently the editors are professors Carlos Roberto Praxedes dos Santos (Public Policy Management) and Graziela Liebel (Health and Work Management).
